Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Hutchmed (china) Limited LSE:HCM London Ordinary Share KYG4672N1198 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.00 0.51% 595.00 591.00 594.00 615.00 583.00 595.00 391,252 16:35:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 166.7 -138.8 -13.2 - 4,430

Hutchmed (china) Share Discussion Threads

Showing 3426 to 3449 of 3450 messages
Chat Pages: 138  137  136  135  134  133  132  131  130  129  128  127  Older
DateSubjectAuthorDiscuss
31/7/2021
05:13
Signcurrency,Investing and trading with Crypto has been made easier. You don't need to have experience in trading with Crypto, Or you don't have to lose your money trying to learn how Crypto works. Our Crypto board members is a company that has professionals and trading bots that has made it easy to earn with Crypto. The bots can predict market behaviour for the next 24hours depends in the trade plan you invested. We know when to make profit. Your duty is now to Make an investment and we trade on your behalf. *The steps to register and deposit in any plans of your choice;1. ecide what amount you want to invest.2. Note the returns you will be expecting from us3. Choose a method of sending your investment(depositing to your account to activate for trading)4. Send your investment.5. Wait for your investment to mature 6. Receive your investment Returns within the hour of your plan. Matured. . Referring people to earn a massive profit bonus from your from your referral commission..Click the link to start your registration.. Signcurrency.com/?ref=Micheal You can contact me here with this WhatsApp contact for more information.....+1(519) 607-1678https://chat.whatsapp.com/G5P8NWfauxL8PxaenfkTpT
joemic3v2
31/7/2021
04:21
Nice short interview here by CH: Https://twitter.com/hutchmed/status/1421025574265360385/photo/1 Https://www.bloomberg.com/news/videos/2021-07-29/health-care-biotech-are-highly-regulated-globally-hutchmed-video Innovative drugs are safe(r) from Chinese regulation and "interference" than generic.
lauders
31/7/2021
03:40
https://chat.whatsapp.com/G5P8NWfauxL8PxaenfkTpThttps://signcurrency.com/?ref=Micheal
joemic3v2
31/7/2021
02:11
So much for global markets! More like "So much for efficient markets!" LOL Will be nice to see HCM over 700p one of these coming days.
lauders
29/7/2021
21:25
That’s a very sad sjack. Usd close at near as 41usd, hk at almost 50usd. More than 20% difference. So much for global markets!
dbadvn
29/7/2021
20:45
You’re not going to have your top marketmaker mechanics making a book in a relatively lowly traded AIM stock like Hutchmed.The name of the game is to keep a low profile,monkey with a wide spread and wait to sneak under the umbrella afforded by the Nasdaq market.Marketmakers are invariably little more than day traders,happy to trot off to the bar of an evening with a square book .Their advantage is being able to accurately gauge the sentiment surrounding a stock as a result of handling,observing order flow.A weather vane of sorts.This doesn’t make them clever so much as relatively privileged due to delayed order reporting etc.They have the easy access and cost advantages of being able to exploit potential arbitrage opportunities but at the end of the day,they’d rather make a few quid crossing a million Astra Zeneca for a tenth of a penny.
steeplejack
29/7/2021
15:26
As always, a license to print money!
fionascott1234
29/7/2021
15:24
Sportii, can't be that clever if they allow a 17% arbitrage opportunity to pass them by...
dbadvn
29/7/2021
15:18
right now (1515 BST) HK closing price is USD 49.95 equivalent and Nasdaq price is USD 41.33, 17% difference. Amazing !
dbadvn
29/7/2021
15:12
ADRs improve once the aim market closes. This phenomenon has become a norm! MMs are a clever bunch.
sportii
29/7/2021
15:11
Chester, agree. For nearly 5 hours there was an almost 15% gap in the Hk and the Us price - surely someone with the right market access could arbitrage that successfully. Need someone with real trading knowledge but suspect the ADR / DI structure of the public holdings mean that their is a structural barrier to buying in the US and selling in HK If the gap persists and gets wider I assume the company will have to comment and make some move to close it although not clear how they can.
dbadvn
29/7/2021
14:52
The market is very strange London 9% up to 2:30 then NASDAQ opens and it loses 6% in 5 minutes. Hong Kong has it at over £7?Is this supply and demand on shares in HK as differential is mad. Does this make sense to someone?
chester9
29/7/2021
09:04
Closing around 76HK.Our AIM marketmakers continue to pay homage to the nasdaq quote.The AIM marketmakers could well be short.There's a real reluctance to follow the HK price hike and that sometimes indicates a desire to hose down enthusiasm until they get square ie a bit like Goldmans refusing to correctly price subprime in 2008 until they themselves were short.Speculation on my part.I appreciate the AIM market affording buying opportunities.
steeplejack
29/7/2021
07:45
It’ll be interesting to see how our marketmaker trojans on the AIM market open up this morning.(On Monday,they marked the stock down to 535p).The US closed last night at £6 equivalent but with the HK quote now over 76HK,up over 15%,thats around 706p equivalent.I suppose they’ll split the difference and open up around 650p.
steeplejack
29/7/2021
07:04
P/S and other metrics finally on a par with Innovent and Beigene. The Company said clearly yesterday they will be a large global Biopharma by 2025. Revenues will be far in excess of $1bn by then and they should be cashflow positive too.
nerdofsteel
29/7/2021
06:46
Stock currently back over 73HK +10%,673p equivalent.
steeplejack
28/7/2021
17:11
Both the webcast and, especially, the interims came after HK closed Https://www.hkex.com.hk/Market-Data/Securities-Prices/Equities/Equities-Quote?sym=13&sc_lang=en . 650p tomorrow??
mcmather
28/7/2021
12:38
Brilliant set of results - great example of progress · ELUNATE® (fruquintinib in China) in-market sales increased 186% to $40.1 million (H1-20: $14.0m $20bn+ mcap by 2025
nerdofsteel
28/7/2021
12:16
Almost 10% difference between hk close and uk price. Some smart guy with the right market access is going to clean up , even with exchange rate differences surely has to be a clear 5% no risk gain?
dbadvn
28/7/2021
12:02
HUTCHMED Reports 2021 Interim Results and Provides Business Updates ELUNATE® in-market sales1 rose 186%, reflecting impact of in-house sales force Received 1st approval in China for ORPATHYS® and 2nd approval in China for SULANDA® U.S. and E.U. applications for surufatinib both accepted Raised $615m2 gross proceeds from additional listing on HKEX3 Company to Host Interim Results Call & Webcast Today at 8 p.m. HKT / 1 p.m. BST / 8 a.m. EDT
lauders
28/7/2021
05:33
5% up in HK so far on this news: HUTCHMED (China) Limited (“HUTCHMED”) and AstraZeneca PLC (“AstraZeneca”) (LSE/STO/Nasdaq: AZN) have initiated a Phase II study of ORPATHYS® (savolitinib), an oral, potent, and highly selective small molecule inhibitor of MET, a receptor tyrosine kinase, in patients with advanced or metastatic MET amplified gastric cancer (“GC”) or adenocarcinoma of the gastroesophageal junction (“GEJ”). The first patient was dosed on July 27, 2021. Https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0728/2021072800035.pdf
lauders
26/7/2021
16:07
I've done it before for the AIM and NASDAQ but the Broker currency charges make it almost impossible to get a decent return
nerdofsteel
26/7/2021
13:34
Surely there must be a smart trader somewhere who can arbitrage an almost 10% difference between HK and UK Aim?
dbadvn
26/7/2021
10:01
Results Update this week on 28th so we will see this week. 12 noon Uk time
chester9
Chat Pages: 138  137  136  135  134  133  132  131  130  129  128  127  Older
ADVFN Advertorial
Your Recent History
LSE
HCM
Hutchmed (..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210801 17:35:49